CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 188,929	$ 154,571
Patient accounts receivable, net	129,484	131,802
Prepaid expenses and other current assets	40,436	26,137
Total current assets	358,849	312,510
NONCURRENT ASSETS
Property and equipment, net	160,615	166,041
Right-of-use assets	143,150	147,878
Intangible assets, net	183,966	190,799
Goodwill	1,293,346	1,293,346
Other noncurrent assets	6,878	7,724
Total noncurrent assets	1,787,955	1,805,788
Total assets	2,146,804	2,118,298
CURRENT LIABILITIES
Accounts payable	7,792	7,242
Accrued payroll expenses	129,187	117,461
Other accrued expenses	46,948	46,942
Operating lease liabilities, current	47,085	49,449
Other current liabilities	11,273	7,792
Total current liabilities	242,285	228,886
NONCURRENT LIABILITIES
Long-term debt, net	272,856	279,790
Operating lease liabilities, noncurrent	143,431	148,699
Deferred tax liability, net	14,129	14,329
Other noncurrent liabilities	182	309
Total noncurrent liabilities	430,598	443,127
Total liabilities	672,883	672,013
COMMITMENTS AND CONTINGENCIES (see Note 11)
STOCKHOLDERS' EQUITY
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of June 30, 2025 and December 31, 2024; 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024	0	0
Common stock - par value $0.01 per share; 800,000 shares authorized as of June 30, 2025 and December 31, 2024; 389,077 and 382,735 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	3,891	3,827
Additional paid-in capital	2,291,056	2,259,818
Accumulated other comprehensive income	345	929
Accumulated deficit	(821,371)	(818,289)
Total stockholders' equity	1,473,921	1,446,285
Total liabilities and stockholders' equity	$ 2,146,804	$ 2,118,298